|
1
|
Kumar P and Aggarwal R: An overview of
triple-negative breast cancer. Arch Gynecol Obstet. 293:247–269.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim A, Jang MH, Lee SJ and Bae YK:
Mutations of the epidermal growth factor receptor gene in
triple-negative breast cancer. J Breast Cancer. 20:150–159. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao Z, Li L, Du P, Ma L, Zhang W, Zheng
L, Lan B, Zhang B, Ma F, Xu B, et al: Transcriptional
downregulation of miR-4306 serves as a new therapeutic target for
triple negative breast cancer. Theranostics. 9:1401–1416. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abramson VG and Mayer IA: Molecular
heterogeneity of triple negative breast cancer. Curr Breast Cancer
Rep. 6:154–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abramson VG, Lehmann BD, Ballinger TJ and
Pietenpol JA: Subtyping of triple-negative breast cancer:
Implications for therapy. Cancer. 121:8–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pandey MK, Gupta SC, Nabavizadeh A and
Aggarwal BB: Regulation of cell signaling pathways by dietary
agents for cancer prevention and treatment. Semin Cancer Biol.
46:158–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao TT and Zhang YQ: Processing and
characterization of silk sericin from bombyx mori and its
application in biomaterials and biomedicines. Mater Sci Eng C Mater
Biol Appl. 61:940–952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang YQ, Tao ML, Shen WD, Zhou YZ, Ding
Y, Ma Y and Zhou WL: Immobilization of L-asparaginase on the
microparticles of the natural silk sericin protein and its
characters. Biomaterials. 25:3751–3759. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yasmin C, Otoi T, Setiadi MA and Karja NW:
Maturation and fertilisation of sheep oocytes cultured in
serum-free medium containing silk protein sericin. Acta Vet Hung.
63:110–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Okazaki Y, Kakehi S, Xu Y, Tsujimoto K,
Sasaki M, Ogawa H and Kato N: Consumption of sericin reduces serum
lipids, ameliorates glucose tolerance and elevates serum
adiponectin in rats fed a high-fat diet. Biosci Biotechnol Biochem.
74:1534–1538. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suktham K, Koobkokkruad T, Wutikhun T and
Surassmo S: Efficiency of resveratrol-loaded sericin nanoparticles:
Promising bionanocarriers for drug delivery. Int J Pharm.
537:48–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song CJ, Fu XM, Li J and Chen ZH: Effects
of sericine on TGF-beta1/Smad3 signal pathway of diabetic
mephropathy rats kidney. Zhongguo Ying Yong Sheng Li Xue Za Zhi.
27:102–105. 2011.(In Chinese). PubMed/NCBI
|
|
13
|
Chen Z, He Y, Song C, Dong Z, Su Z and Xue
J: Sericin can reduce hippocampal neuronal apoptosis by activating
the Akt signal transduction pathway in a rat model of diabetes
mellitus. Neural Regen Res. 7:197–201. 2012.PubMed/NCBI
|
|
14
|
Song CJ, Yang ZJ, Tang QF and Chen ZH:
Effects of sericin on the testicular growth hormone/insulin-like
growth factor-1 axis in a rat model of type 2 diabetes. Int J Clin
Exp Med. 8:10411–10419. 2015.PubMed/NCBI
|
|
15
|
Guo WH, Chen ZY, Chen H, Lin T, Zhao ML,
Liu H, Yu J, Hu YF and Li GX: Sericin regulates proliferation of
human gastric cancer MKN45 cells through autophagic pathway. Nan
Fang Yi Ke Da Xue Xue Bao. 38:148–154. 2018.(In Chinese).
PubMed/NCBI
|
|
16
|
Kaewkorn W, Limpeanchob N, Tiyaboonchai W,
Pongcharoen S and Sutheerawattananonda M: Effects of silk sericin
on the proliferation and apoptosis of colon cancer cells. Biol Res.
45:45–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sasaki M, Kato N, Watanabe H and Yamada H:
Silk protein, sericin, suppresses colon carcinogenesis induced by
1,2-dimethylhydrazine in mice. Oncol Rep. 7:1049–1052.
2000.PubMed/NCBI
|
|
18
|
Zhaorigetu S, Sasaki M, Watanabe H and
Kato N: Supplemental silk protein, sericin, suppresses colon
tumorigenesis in 1,2-dimethylhydrazine-treated mice by reducing
oxidative stress and cell proliferation. Biosci Biotechnol Biochem.
65:2181–2186. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhaorigetu S, Yanaka N, Sasaki M, Watanabe
H and Kato N: Inhibitory effects of silk protein, sericin on
UVB-induced acute damage and tumor promotion by reducing oxidative
stress in the skin of hairless mouse. J Photochem Photobiol B.
71:11–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhaorigetu S, Yanaka N, Sasaki M, Watanabe
H and Kato N: Silk protein, sericin, suppresses DMBA-TPA-induced
mouse skin tumorigenesis by reducing oxidative stress, inflammatory
responses and endogenous tumor promoter TNF-alpha. Oncol Rep.
10:537–543. 2003.PubMed/NCBI
|
|
21
|
Kumar JP and Mandal BB: Silk sericin
induced pro-oxidative stress leads to apoptosis in human cancer
cells. Food Chem Toxicol. 123:275–287. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Santucci-Pereira J, Zeleniuch-Jacquotte A,
Afanasyeva Y, Zhong H, Slifker M, Peri S, Ross EA, López de Cicco
R, Zhai Y, Nguyen T, et al: Genomic signature of parity in the
breast of premenopausal women. Breast Cancer Res. 21:462019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Burstein MD, Tsimelzon A, Poage GM,
Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK,
Hilsenbeck SG, Chang JC, et al: Comprehensive genomic analysis
identifies novel subtypes and targets of triple-negative breast
cancer. Clin Cancer Res. 21:1688–1698. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Edgar R, Domrachev M and Lash AE: Gene
expression omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanehisa M: Toward understanding the
origin and evolution of cellular organisms. Protein Sci.
28:1947–1951. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kunz RI, Brancalhão RM, Ribeiro LF and
Natali MR: Silkworm sericin: Properties and biomedical
applications. Biomed Res Int. 2016:81757012016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jena K, Pandey JP, Kumari R, Sinha AK,
Gupta VP and Singh GP: Tasar silk fiber waste sericin: New source
for anti-elastase, anti-tyrosinase and anti-oxidant compounds. Int
J Biol Macromol. 114:1102–1108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aramwit P, Kanokpanont S, De-Eknamkul W
and Srichana T: Monitoring of inflammatory mediators induced by
silk sericin. J Biosci Bioeng. 107:556–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Purdy A, Uyetake L, Cordeiro MG and Su TT:
Regulation of mitosis in response to damaged or incompletely
replicated DNA require different levels of Grapes (Drosophila
Chk1). J Cell Sci. 118:3305–3315. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
John RR, Malathi N, Ravindran C and
Anandan S: Mini review: Multifaceted role played by cyclin D1 in
tumor behavior. Indian J Dent Res. 28:187–192. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lim S and Kaldis P: Cdks, cyclins and
CKIs: Roles beyond cell cycle regulation. Development.
140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Besson A, Dowdy SF and Roberts JM: CDK
inhibitors: Cell cycle regulators and beyond. Dev Cell. 14:159–169.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roninson IB: Oncogenic functions of tumour
suppressor p21(Waf1/Cip1/Sdi1): Association with cell senescence
and tumour-promoting activities of stromal fibroblasts. Cancer
Lett. 179:1–14. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suzuki A, Tsutomi Y, Miura M and Akahane
K: Caspase 3 inactivation to suppress Fas-mediated apoptosis:
Identification of binding domain with p21 and ILP and inactivation
machinery by p21. Oncogene. 18:1239–1244. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zagorac I, Fernandez-Gaitero S, Penning R,
Post H, Bueno MJ, Mouron S, Manso L, Morente MM, Alonso S, Serra V,
et al: In vivo phosphoproteomics reveals kinase activity profiles
that predict treatment outcome in triple-negative breast cancer.
Nat Commun. 9:35012018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang C, Han Y, Huang H, Min L, Qu L and
Shou C: Integrated analysis of expression profiling data identifies
three genes in correlation with poor prognosis of triple-negative
breast cancer. Int J Oncol. 44:2025–2033. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bao C, Lu Y, Chen J, Chen D, Lou W, Ding
B, Xu L and Fan W: Exploring specific prognostic biomarkers in
triple-negative breast cancer. Cell Death Dis. 10:8072019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
den Hollander P, Rawls K, Tsimelzon A,
Shepherd J, Mazumdar A, Hill J, Fuqua SA, Chang JC, Osborne CK,
Hilsenbeck SG, et al: Phosphatase PTP4A3 promotes triple-negative
breast cancer growth and predicts poor patient survival. Cancer
Res. 76:1942–1953. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Neckers L and Workman P: Hsp90 molecular
chaperone inhibitors: Are we there yet? Clin Cancer Res. 18:64–76.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He Y, Peng S, Wang J, Chen H, Cong X, Chen
A, Hu M, Qin M, Wu H, Gao S, et al: Ailanthone targets p23 to
overcome MDV3100 resistance in castration-resistant prostate
cancer. Nat Commun. 7:131222016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mangé A, Coyaud E, Desmetz C, Laurent E,
Béganton B, Coopman P, Raught B and Solassol J: FKBP4 connects
mTORC2 and PI3K to activate the PDK1/Akt-dependent cell
proliferation signaling in breast cancer. Theranostics.
9:7003–7015. 2019. View Article : Google Scholar : PubMed/NCBI
|
